Arcadia Biosciences (NASDAQ:RKDA) Releases Earnings Results, Beats Estimates By $0.75 EPS

Arcadia Biosciences (NASDAQ:RKDA) announced its quarterly earnings data on Thursday. The basic materials company reported $0.29 earnings per share for the quarter, topping the consensus estimate of ($0.46) by $0.75, FiscalAI reports. The business had revenue of $1.62 million for the quarter, compared to analyst estimates of $2.40 million. Arcadia Biosciences had a negative net margin of 234.53% and a negative return on equity of 183.50%.

Arcadia Biosciences Trading Down 6.6%

NASDAQ:RKDA traded down $0.02 on Thursday, hitting $0.22. 2,606,388 shares of the stock were exchanged, compared to its average volume of 1,580,873. The stock has a market cap of $535,020.00, a PE ratio of -0.05 and a beta of 0.63. The stock has a fifty day moving average of $0.29 and a 200-day moving average of $0.94. Arcadia Biosciences has a fifty-two week low of $0.11 and a fifty-two week high of $3.87.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Arcadia Biosciences in a report on Tuesday, September 22nd. One analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock currently has an average rating of “Sell”.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc. is an agricultural biotechnology company focused on developing and commercializing food ingredients and crop-based products intended to support health and wellness. The company applies plant science and breeding technologies to develop crops with enhanced nutritional characteristics and products designed for consumer and food-industry applications. Its product portfolio has included GoodWheat, a wheat variety developed with increased dietary fiber and other nutritional attributes, as well as GoodHemp, a line of hemp-based food products and ingredients.